Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 72

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 72
---
 from time to time, which could cause substantial damage to NewGenIvf if not covered
by professional malpractice liability insurance. Any dispute with clients, or any legal proceeding involving the physicians of the medical
facilities or medical professionals, regardless of its merit or eventual outcome, could result in significant legal costs and financial
and/or reputational damages to the medical facilities and NewGenIvf and materially and adversely affect the business, financial condition
and results of operations of the medical facilities in NewGenIvf’s network, and further affect its business, financial condition,
results of operations and prospects.

NewGenIvf may not be successful in adapting to technological developments, which may affect its business and results of operations.

It is possible that new technologies
could be developed or scientific advances made by NewGenIvf’s competitors, or elsewhere and licensed to NewGenIvf’s competitors,
which cannot be replicated by NewGenIvf without significant capital expenditure or at all, or that replace or reduce the requirement for
assisted reproductive services, ultrasound or specialized diagnostics. The consequences for NewGenIvf of the development of new technologies
could include lower or loss of revenues, loss of market position and reduced prospects of NewGenIvf.

If its computer systems, or those of its providers, specialty pharmacies or other downstream vendors lag, fail or suffer security breaches, NewGenIvf may incur a material disruption of its services, which could materially impact its business and the results of operations.

NewGenIvf’s businesses
in Thailand, Cambodia and Kyrgyzstan are increasingly dependent on critical, complex and interdependent information technology systems
to support business processes as well as internal and external communications. NewGenIvf’s success is therefore dependent in part
on its ability to secure, integrate, develop, redesign and enhance its (or contract with vendors to provide) technology systems that support
its business strategy initiatives and processes in a compliant, secure, and cost and resource efficient manner. If NewGenIvf or its providers,
specialty pharmacies or other downstream vendors have an issue with its or their respective technology systems, it may result in a disruption
to its operations or downstream disruption to its relationships with its clients or its selective network of high-quality fertility specialists.
Additionally, if NewGenIvf chooses to insource any of the services currently handled by a third party, it may result in technological
or operational disruptions.

In addition, despite the implementation
of security measures, its internal computer systems, and those of its provider clinics, specialty pharmacies